Embedded Files
To empower individuals with Parkinson’s disease through innovative technology, enabling better management of their condition and improving their overall quality of life.
Parkinson's disease (PD) is a progressive neurological disorder affecting movement control, characterized by tremors, rigidity, and bradykinesia (slowness of movement). In the U.S., approximately 1 million people live with Parkinson’s, while globally, the number exceeds 10 million. Current treatments primarily manage symptoms rather than stop or slow the underlying neurodegeneration, and as the disease progresses, these treatments often become less effective.
Managing Parkinson’s disease (PD) medications is challenging due to:
Symptom Fluctuation: Symptoms vary throughout the day, complicating dosage and timing.
Side Effects: Medications can cause nausea, dizziness, and involuntary movements.
Drug Interactions: Multiple medications increase the risk of adverse effects.
Disease Progression: Medications become less effective over time, requiring adjustments.
Individual Variation: Responses to treatment differ, needing personalized plans.
These factors make it essential for patients to work closely with healthcare providers to tailor their medication regimen effectively.
The goal of this app is to close this gap between patients and healthcare professionals by leveraging technology to provide actionable insights and improve patient care. NeuroNest is poised to make a significant impact in the management of Parkinson’s disease with a clear vision, innovative features, and a solid business strategy. It aims to enhance the lives of those affected by Parkinson’s disease and establish itself as a leader in digital health solutions.
Google Sites
Report abuse